Biotricity is trading 17.02% lower at $0.07 as the immediate catalyst remains unclear. - No company-specific announcement, filing, earnings release, FDA update, financing, partnership or analyst action was identified for September 23, 2026. - OTC Markets lists September 18 as Biotricity’s latest disclosed September 2026 item, with no newer release shown. - The broader market is only modestly lower and does not clearly explain the drop; the move may reflect thin liquidity, and delayed disclosures should be rechecked.